Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast CancerQiang Fu, Wei Zhong|Frontiers in Cell and Developmental Biology|2021Cited by 11